A Prospective Multicenter Study of Partially Covered Metal Stents in Patients Receiving Neoadjuvant Chemotherapy for Resectable and Borderline Resectable Pancreatic Cancer: BTS-NAC Study
2
조회
0
다운로드
3
인용
0
참고문헌
키워드
초록
Background/Aims: The aim of this study was to evaluate the safety and efficacy of partially covered self-expandable metallic stents (PCSEMS) in patients undergoing neoadjuvant chemo (radio) therapy (NAC) for pancreatic cancer (PC). Methods: This was a prospective multicenter study to evaluate the safety and efficacy of PCSEMS in patients receiving NAC for resectable and borderline resectable PC. The primary endpoint was the rate of recurrent biliary obstruction (RBO). Results: Twenty-six patients with PC (three with resectable PC and 23 with borderline resectable PC) who underwent NAC at seven Japanese centers were included in the analysis. Both the technical and functional success rates of PCSEMS placement were 100%. Early stent-related complications were observed in three patients (11.5%): mild pancreatitis (n=2) and mild liver abscess (n=1). The median time to surgery or palliation was 4.0 months. Surgical resection was eventually performed in 73.1% of patients, and stent removal during surgery was successful in all patients. RBO was observed in nine patients (34.6%): seven with stent occlusion, one with kinking and one with migration. The RBO rates in resected cases and nonresected cases were 36.8% and 28.6%, respectively. Conclusions: Biliary drainage by PCSEMS was safe and feasible in patients undergoing NAC for resectable and borderline resectable PC.
Abstract
Background/Aims: The aim of this study was to evaluate the safety and efficacy of partially covered self-expandable metallic stents (PCSEMS) in patients undergoing neoadjuvant chemo (radio) therapy (NAC) for pancreatic cancer (PC). Methods: This was a prospective multicenter study to evaluate the safety and efficacy of PCSEMS in patients receiving NAC for resectable and borderline resectable PC. The primary endpoint was the rate of recurrent biliary obstruction (RBO). Results: Twenty-six patients with PC (three with resectable PC and 23 with borderline resectable PC) who underwent NAC at seven Japanese centers were included in the analysis. Both the technical and functional success rates of PCSEMS placement were 100%. Early stent-related complications were observed in three patients (11.5%): mild pancreatitis (n=2) and mild liver abscess (n=1). The median time to surgery or palliation was 4.0 months. Surgical resection was eventually performed in 73.1% of patients, and stent removal during surgery was successful in all patients. RBO was observed in nine patients (34.6%): seven with stent occlusion, one with kinking and one with migration. The RBO rates in resected cases and nonresected cases were 36.8% and 28.6%, respectively. Conclusions: Biliary drainage by PCSEMS was safe and feasible in patients undergoing NAC for resectable and borderline resectable PC.
참고문헌 (28)
- Isayama H, "A prospective randomised study of"covered"versus"uncovered"diamond stents for the management of distal malignant biliary obstruction", Gut, 53, pp.729~734 (2004)
- Kitano M, "Covered selfexpandable metal stents with an anti-migration system improve patency duration without increased complications compared with uncovered stents for distal biliary obstruction caused by pancreatic carcinoma : a randomized multicenter trial", Am J Gastroenterol, 108, pp.1713~1722 (2013)
- Lee JH, "Comparison of the utility of covered metal stents versus uncovered metal stents in the management of malignant biliary strictures in 749 patients", Gastrointest Endosc, 78, pp.312~324 (2013)
- van der Gaag NA, "Preoperative biliary drainage for cancer of the head of the pancreas", N Engl J Med, 362, pp.129~137 (2010)
- Cavell LK, "Biliary self-expandable metal stents do not adversely affect pancreaticoduodenectomy", Am J Gastroenterol, 108, pp.1168~1173 (2013)
- Blazer M, "Neoadjuvant modified(m)FOLFIRINOX for locally advanced unresectable(LAPC)and borderline resectable(BRPC)adenocarcinoma of the pancreas", Ann Surg Oncol, 22, pp.1153~1159 (2015)
- Murakami Y, "Survival impact of neoadjuvant gemcitabine plus S-1 chemotherapy for patients with borderline resectable pancreatic carcinoma with arterial contact", Cancer Chemother Pharmacol, 79, pp.37~47 (2017)
- Gardner TB, "Cost-effectiveness and clinical efficacy of biliary stents in patients undergoing neoadjuvant therapy for pancreatic adenocarcinoma in a randomized controlled trial", Gastrointest Endosc, 84, pp.460~466 (2016)
- Togawa O, "Preoperative biliary drainage using a fully covered self-expandable metallic stent for pancreatic head cancer : a prospective feasibility study", Saudi J Gastroenterol, 24, pp.151~156 (2018)
- Tempero MA, "Pancreatic Adenocarcinoma, version 2. 2012 : featured updates to the NCCN Guidelines", J Natl Compr Canc Netw, 10, pp.703~713 (2012)
- Isayama H, "TOKYO criteria 2014for transpapillary biliary stenting", Dig Endosc, 27, pp.259~264 (2015)
- Eisenhauer EA, "New response evaluation criteria in solid tumours : revised RECIST guideline(version 1. 1)", Eur J Cancer, 45, pp.228~247 (2009)
- Aadam AA, "Efficacy and safety of self-expandable metal stents for biliary decompression in patients receiving neoadjuvant therapy for pancreatic cancer : a prospective study", Gastrointest Endosc, 76, pp.67~75 (2012)
- Kubota K, "Covered self-expandable metal stent deployment promises safe neoadjuvant chemoradiation therapy in patients with borderline resectable pancreatic head cancer", Dig Endosc, 26, pp.77~86 (2014)
- Pop GH, "Bridge to surgery using partially covered self-expandable metal stents (PCMS) in malignant biliary stricture: an acceptable paradigm?", Surg Endosc, 25, pp.613~618 (2011)
- Hamada T, "Duodenal invasion is a risk factor for the early dysfunction of biliary metal stents in unresectable pancreatic cancer", Gastrointest Endosc, 74, pp.548~555 (2011)
- Singal AK, "Self-expanding metal stents for biliary drainage in patients with resectable pancreatic cancer : single-center experience with 79 cases", Dig Dis Sci, 56, pp.3678~3684 (2011)
- De Pastena M, "Impact of preoperative biliary drainage on postoperative outcome after pancreaticoduodenectomy : an analysis of 1500 consecutive cases", Dig Endosc, 30, pp.777~784 (2018)
- Saleem A, "Meta-analysis of randomized trials comparing the patency of covered and uncovered self-expandable metal stents for palliation of distal malignant bile duct obstruction", Gastrointest Endosc, 74, pp.321~327 (2011)
- Almadi MA, "No benefit of covered vs uncovered self-expandable metal stents in patients with malignant distal biliary obstruction : a meta-analysis", Clin Gastroenterol Hepatol, 11, pp.27~37 (2013)
- Seo DW, "Covered and uncovered biliary metal stents provide similar relief of biliary obstruction during neoadjuvant therapy in pancreatic cancer : a randomized trial", Gastrointest Endosc, 90, pp.602~612 (2019)
- Isayama H, "Comparison of partially covered nitinol stents with partially covered stainless stents as a historical control in a multicenter study of distal malignant biliary obstruction : the WATCH study", Gastrointest Endosc, 76, pp.84~92 (2012)
- Kogure H, "A prospective multicenter study of a fully covered metal stent in patients with distal malignant biliary obstruction : WATCH-2 study", Dig Dis Sci, 63, pp.2466~2473 (2018)
- Kawakubo K, "Risk factors for pancreatitis following transpapillary self-expandable metal stent placement", Surg Endosc, 26, pp.771~776 (2012)
- CotéGA, "Risk of post-ERCP pancreatitis with placement of self-expandable metallic stents", Gastrointest Endosc, 72, pp.748~754 (2010)
- Hayashi T, "No benefit of endoscopic sphincterotomy before biliary placement of selfexpandable metal stents for unresectable pancreatic cancer", Clin Gastroenterol Hepatol, 13, pp.1151~1158 (2015)
- Isayama H, "Cholecystitis after metallic stent placement in patients with malignant distal biliary obstruction", Clin Gastroenterol Hepatol, 4, pp.1148~1153 (2006)
- Suk KT, "Risk factors for cholecystitis after metal stent placement in malignant biliary obstruction", Gastrointest Endosc, 64, pp.522~529 (2006)